These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 12937159

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.
    Yu S, Asa SL, Weigel RJ, Ezzat S.
    J Biol Chem; 2003 May 30; 278(22):19597-602. PubMed ID: 12642581
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
    Abbass SA, Asa SL, Ezzat S.
    J Clin Endocrinol Metab; 1997 Apr 30; 82(4):1160-6. PubMed ID: 9100589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
    Yu SJ, Zheng L, Ladanyi M, Asa SL, Ezzat S.
    Clin Cancer Res; 2004 Oct 01; 10(19):6750-8. PubMed ID: 15475466
    [Abstract] [Full Text] [Related]

  • 12. Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia.
    Ezzat S, Zheng L, Asa SL.
    Mol Endocrinol; 2004 Oct 01; 18(10):2543-52. PubMed ID: 15231874
    [Abstract] [Full Text] [Related]

  • 13. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.
    Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X, Klibanski A.
    Mol Endocrinol; 2000 Dec 01; 14(12):2066-75. PubMed ID: 11117535
    [Abstract] [Full Text] [Related]

  • 14. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L, Goodman PA, Wood CM, Crotty ML, Sensel M, Sather H, Navara C, Nachman J, Steinherz PG, Gaynon PS, Seibel N, Vassilev A, Juran BD, Reaman GH, Uckun FM.
    J Clin Oncol; 1999 Dec 01; 17(12):3753-66. PubMed ID: 10577847
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A.
    J Clin Endocrinol Metab; 1996 Feb 01; 81(2):783-90. PubMed ID: 8636304
    [Abstract] [Full Text] [Related]

  • 16. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
    Zhou F, Mei H, Jin R, Li X, Chen X.
    J Pediatr Hematol Oncol; 2011 Aug 01; 33(6):429-32. PubMed ID: 21792038
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.
    Koipally J, Renold A, Kim J, Georgopoulos K.
    EMBO J; 1999 Jun 01; 18(11):3090-100. PubMed ID: 10357820
    [Abstract] [Full Text] [Related]

  • 20. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S.
    J Clin Endocrinol Metab; 1996 Jun 01; 81(6):2165-70. PubMed ID: 8964846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.